Mir Hadi Razeghi Kondelaji

Mir Hadi Razeghi Kondelaji serves as a Research Fellow at the Morgridge Institute for Research, specializing in Biomedical Imaging with a focus on developing novel diagnostic and therapeutic approaches for cancer and neurodegenerative disorders.

Education:

• PhD in Biomedical Engineering, Medical College of Wisconsin (May 2024)

Research Focus: His work integrates advanced imaging modalities and nano-engineered therapeutic systems to address critical challenges in oncology and Alzheimer's disease. Key initiatives include developing label-free biomarkers for Alzheimer's diagnosis, vascular-targeted plasmonic tumor ablation, and radiation injury mitigation strategies using molecular imaging techniques. His methodology bridges computational modeling, in vivo experimentation, and clinical translation.

Publication Trends: Analysis of his 2018-2024 publications reveals dominant themes in multimodal imaging (NIR, fluorescence, MRI/X-ray contrast) and nanoparticle-mediated interventions for solid tumors. The research trajectory shows progressive specialization in vascular-targeted therapies, with increasing emphasis on combinatorial approaches integrating photothermal ablation, radiation oncology, and biomaterial engineering for precision medicine applications.

Research Environment: Operating within Morgridge's interdisciplinary ecosystem, his work leverages state-of-the-art imaging platforms and nanofabrication facilities. Collaborations span radiation oncology, biomedical engineering, and molecular biology teams to accelerate therapeutic development from bench to bedside, particularly in head/neck cancer and radiation injury contexts.